Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management, represents a new class of medication that simultaneously activates two hormone receptors. Clinical trials have shown weight loss and blood sugar improvements that surpass anything previously seen in pharmaceutical treatment.
What Makes Tirzepatide Different?
Unlike semaglutide, which activates only the GLP-1 receptor, tirzepatide is a dual GIP/GLP-1 receptor agonist. It activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor simultaneously. This dual action appears to produce synergistic effects on insulin secretion, appetite suppression, and fat metabolism that exceed what either mechanism achieves alone.
Clinical Trial Results
| Trial | Key Finding |
|---|---|
| SURPASS-2 (vs semaglutide 1mg) | Tirzepatide 15mg reduced HbA1c by 2.46% vs 2.08% for semaglutide; greater weight loss |
| SURMOUNT-1 (obesity, no diabetes) | Average weight loss of 22.5% of body weight at highest dose |
| SURMOUNT-2 (obesity with T2D) | Average weight loss of 15.7% of body weight |
Dosing and Administration
Tirzepatide is administered as a once-weekly subcutaneous injection. The starting dose is 2.5 mg weekly, with dose escalation every four weeks to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and a maximum of 15 mg. The gradual escalation schedule is designed to minimise gastrointestinal side effects.
⚠️ Important Contraindications
Tirzepatide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It should not be used during pregnancy. Always discuss your full medical history with your prescriber before starting treatment.
✅ Key Takeaway
Tirzepatide represents a genuine step forward in diabetes and obesity pharmacotherapy. Its dual mechanism produces blood sugar reductions and weight loss that surpass previous treatments. For people with Type 2 diabetes who have not achieved their targets with existing medications, it is worth discussing with your healthcare team whether tirzepatide is appropriate for you.
English 
Urdu